These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702 [TBL] [Abstract][Full Text] [Related]
44. [Tardive dyskinesia in patients with schizophrenia treated with olanzapine - results from a 20-month, prospective, open study under naturalistic conditions]. Szafrański T Psychiatr Pol; 2014; 48(6):1155-65. PubMed ID: 25717485 [TBL] [Abstract][Full Text] [Related]
45. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia. McGrath JJ; Soares KV Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546 [TBL] [Abstract][Full Text] [Related]
46. The effects of eicosapentaenoic acid in tardive dyskinesia: a randomized, placebo-controlled trial. Emsley R; Niehaus DJ; Koen L; Oosthuizen PP; Turner HJ; Carey P; van Rensburg SJ; Maritz JS; Murck H Schizophr Res; 2006 May; 84(1):112-20. PubMed ID: 16632329 [TBL] [Abstract][Full Text] [Related]
47. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study. Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810 [TBL] [Abstract][Full Text] [Related]
59. The treatment of tardive dyskinesia. Raja M Schweiz Arch Neurol Psychiatr (1985); 1996; 147(1):13-8. PubMed ID: 8685689 [TBL] [Abstract][Full Text] [Related]
60. Melatonin for the treatment of tardive dyskinesia. Nelson LA; McGuire JM; Hausafus SN Ann Pharmacother; 2003; 37(7-8):1128-31. PubMed ID: 12841828 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]